Ignite Creation Date:
2024-05-06 @ 2:58 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04480086
Status:
TERMINATED
Last Update Posted:
2023-08-29
First Post:
2020-07-20
Brief Title:
Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis
Sponsor:
AbbVie
Organization:
AbbVie
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-17
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-28
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-20
First Submit QC Date:
July 20 2020
Study First Post Date:
2020-07-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-25
Last Update Post Date:
2023-08-29
Last Update Post Date Type:
ACTUAL